About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Regulatory and Clinical

Catalyst Category

Regulatory and Clinical

Live feed of every catalyst classified under Regulatory and Clinical.

CATALYSTS IN FEED

168

AVG MAX MOVE

+116.8%

POSITIVE MOVES

100%

LARGEST MOVE

+664.1%

DSMB Efficacy Met FDA 510(k) Cleared FDA Approval FDA Fast Track FDA Meeting FDA Meeting Granted Generic Drug Approved Inconclusive Topline Results IND Cleared for Study IND Filed NDA Resubmission Orphan Drug Designation Positive Subgroup Data Positive Topline Results Primary Endpoint Met SPA Agreement Study Complete Trial Enrollment Complete

Range–

Showing 7 of 168

Regulatory and ClinicalOct 27, 2025 · 7:59pm ET

VSEEVSee Health, Inc. Common Stock

VSee Health Granted FedRAMP High Level Authorization by U.S. Department of Health and Human Services

The authorization allows VSee Health to operate at the highest security level for federal cloud services.

Be first on the next Regulatory and Clinical catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+535.3%

RVOL

3.0x

Max high

$4.03

Fuel

1h 16m

Regulatory and ClinicalOct 27, 2025 · 7:59pm ET

VSEEVSee Health, Inc. Common Stock+535.3%

VSee Health Granted FedRAMP High Level Authorization by U.S. Department of Health and Human Services

RVOL

3.0x

Max high

$4.03

Fuel

1h 16m

Regulatory and ClinicalOct 23, 2025 · 7:03pm ET

NRXSNeuraxis, Inc.

Neuraxis Receives FDA Clearance for PENFS Technology to Treat Functional Abdominal Pain and Nausea

Clearance expands treatment options for patients aged 8 and older.

Regulatory and ClinicalOct 23, 2025 · 7:03pm ET

NRXSNeuraxis, Inc.+53.3%

Neuraxis Receives FDA Clearance for PENFS Technology to Treat Functional Abdominal Pain and Nausea

Regulatory and ClinicalOct 21, 2025 · 7:51pm ET

ARMPArmata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 Bacteriophage Cocktail

Results presented in a late-breaking oral presentation at IDWeek 2025.

Regulatory and ClinicalOct 21, 2025 · 7:51pm ET

ARMPArmata Pharmaceuticals, Inc. Common Stock+366.9%

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 Bacteriophage Cocktail

Regulatory and ClinicalOct 20, 2025 · 8:02am ET

Azitra Announces Positive Preclinical Data for ATR-01 Program

Company releases promising results for treatment of Ichthyosis Vulgaris.

Regulatory and ClinicalOct 20, 2025 · 8:02am ET

AZTRAzitra Inc+78.8%

Azitra Announces Positive Preclinical Data for ATR-01 Program

Regulatory and ClinicalOct 20, 2025 · 7:00am ET

REPLReplimune Group, Inc.

FDA Accepts Replimune Group's BLA Resubmission for RP1

Regulatory review process for the company's lead candidate begins.

Regulatory and ClinicalOct 20, 2025 · 7:00am ET

REPLReplimune Group, Inc.+128.7%

FDA Accepts Replimune Group's BLA Resubmission for RP1

Regulatory and ClinicalOct 15, 2025 · 7:51pm ET

FEMYFEMASYS INC

Femasys Inc. to Exhibit at the ASRM 2025 Scientific Congress & Expo

Company to showcase innovations in reproductive health at industry event.

Regulatory and ClinicalOct 15, 2025 · 7:51pm ET

FEMYFEMASYS INC+50.0%

Femasys Inc. to Exhibit at the ASRM 2025 Scientific Congress & Expo

Regulatory and ClinicalOct 7, 2025 · 7:58pm ET

GTBPGT Biopharma, Inc.

GT Biopharma Provided Enrollment Update on Phase 1 Trial of GTB-3650

The update pertains to the treatment of relapsed or refractory CD33 expressing hematologic malignancies.

Regulatory and ClinicalOct 7, 2025 · 7:58pm ET

GTBPGT Biopharma, Inc.+87.6%

GT Biopharma Provided Enrollment Update on Phase 1 Trial of GTB-3650

1
…
12
13
14
…
24

RVOL

13.4x

Max high

$5.96

Fuel

8m

RVOL

13.6x

Max high

$16.34

Fuel

32m

RVOL

4.9x

Max high

$1.26

Fuel

27m

RVOL

9.4x

Max high

$10.29

Fuel

5h 9m

RVOL

4.4x

Max high

$16.80

Fuel

4h 56m

RVOL

3.8x

Max high

$1.37

Fuel

4h 26m